ProCE Banner Activity

An Expert’s Guide to ASH 2022: Preview of the Top Abstracts

Conference Coverage
Clinical Thought

Read expert highlights of key studies being presented at the upcoming 2022 ASH Annual Meeting and Exposition. CCO’s Independent Conference Coverage will include all the information you need to understand and integrate the latest oncology data into your clinical practice.

Released: December 07, 2022

Expiration: December 06, 2023

Share

Faculty

Catherine M. Broome

Catherine M. Broome, MD

Professor of Medicine
Division of Hematology/Oncology
MedStar Georgetown University Hospital
Washington, DC

John M. Burke

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

Corey Cutler

Corey Cutler, MD, MPH, FRCPC

Associate Professor of Medicine
Harvard Medical School
Medical Director, Stem Cell Transplantation
Dana-Farber Cancer Institute
Boston, Massachusetts

David Dingli

David Dingli, MD, PhD

Professor of Medicine
Division of Hematology
Mayo Clinic College of Science and Medicine
Rochester, Minnesota

Amir Fathi

Amir Fathi, MD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Division of Hematology/Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Shaji K. Kumar

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

Sagar Lonial

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Peter Martin

Peter Martin, MD

Professor of Medicine
Weill Cornell Medicine
New York, New York

Marshall Mazepa

Marshall Mazepa, MD

Assistant Professor of Medicine
Division of Hematology, Oncology and Transplantation
University of Minnesota
Minneapolis, Minnesota

Srdan Verstovsek

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Eunice S. Wang

Eunice S. Wang, MD

Chief, Leukemia and Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Allison P Wheeler

Allison P Wheeler, MD, MSCI

Director of Research at Washington Center for Bleeding Disorders
Associate Professor, University of Washington School of Medicine
Division of Pediatric Hematology/Oncology & Division of Hematology and Oncology
Seattle, Washington

Amer Zeidan

Amer Zeidan, MBBS, MHS

Associate Professor of Medicine (Hematology)
Chief, Division of Hematologic Malignancies
Yale Comprehensive Cancer Center and Smilow Cancer Hospital
New Haven, Connecticut

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Amgen

AstraZeneca

Epizyme

GSK

Incyte Corporation

Jazz Pharmaceuticals

Karyopharm Therapeutics Inc.

Novartis Pharmaceuticals Corporation

Sanofi

Seagen

Faculty Disclosure

Primary Author

Catherine M. Broome, MD

Professor of Medicine
Division of Hematology/Oncology
MedStar Georgetown University Hospital
Washington, DC

Catherine M. Broome, MD: consultant/advisor/speaker: Alexion, Incyte, Sanofi; researcher: Argenx.

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

John M. Burke, MD: consultant/advisor/speaker: AbbVie, Adaptive Biotechnologies, AstraZeneca, BeiGene, Bristol-Myers Squibb, Epizyme, Kura, Kymera, MorphoSys, Novartis, Nurix, Roche/Genentech, Seattle Genetics, TG Therapeutics, Verastem, X4 Pharmaceuticals; researcher: MorphoSys; speakers bureau: BeiGene, Seattle Genetics.

Corey Cutler, MD, MPH, FRCPC

Associate Professor of Medicine
Harvard Medical School
Medical Director, Stem Cell Transplantation
Dana-Farber Cancer Institute
Boston, Massachusetts

Corey Cutler, MD, MPH, FRCPC: consultant/advisor/speaker: CSL Behring, CTI Biopharma, Equillium, Incyte, Janssen, Jazz, Mallinckrodt, Sanofi; other: Cimeio.

David Dingli, MD, PhD

Professor of Medicine
Division of Hematology
Mayo Clinic College of Science and Medicine
Rochester, Minnesota

David Dingli, MD, PhD: consultant: Alexion, Apellis, Janssen, Novartis, Sanofi, Takeda; independent contractor: Sorrento Therapeutics.

Amir Fathi, MD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Division of Hematology/Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Amir T. Fathi, MD: consultant/advisor/speaker/: AbbVie, Agios, Amgen, Astellas, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Enclear, Foghorn, Forma, Genentech, Immunogen, Ipsen, Kite, Mablytics, MorphoSys, Novartis, Orum, Pfizer, PureTech, Servier, Takeda.

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

Shaji K. Kumar, MD: consultant/advisor (paid to institution): AbbVie, Amgen, Antengene, ArcellX, AstraZeneca, Beigene, Bluebird Bio, Bristol-Myers Squibb, Janssen, K36, Loxo Oncology, Oncopeptides, Roche/Genentech, Sanofi, Secura Biotherapeutics, Takeda, Trillium; researcher (paid to institution): AbbVie, Allogene, Amgen, AstraZeneca, Bristol-Myers Squibb, Carsgen, GlaxoSmithKline, Janssen, Novartis, Regeneron, Roche/Genentech, Takeda.

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Sagar Lonial, MD: consultant/advisor/speaker: AbbVie, Bluebird, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Pfizer, Takeda; other financial or material support: TG Therapeutics

Peter Martin, MD

Professor of Medicine
Weill Cornell Medicine
New York, New York

Peter Martin, MD: consultant/advisor/speaker: ADC Therapeutics, AstraZeneca, BeiGene, Bristol-Myers Squibb, Daiichi Sankyo, Epizyme, Genentech, Gilead Sciences, Janssen, Takeda.

Marshall Mazepa, MD

Assistant Professor of Medicine
Division of Hematology, Oncology and Transplantation
University of Minnesota
Minneapolis, Minnesota

Marshall Mazepa, MD: non-CME/CE services: Sanofi.

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Srdan Verstovsek, MD, PhD: researcher: Bristol-Myers Squibb, CTI, Incyte, PharmaEssentia, Protagonist, Roche, Sierra.

Eunice S. Wang, MD

Chief, Leukemia and Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Eunice S. Wang, MD: consultant/advisor/speaker: AbbVie, Amgen, Astellas, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Janssen, Jazz, Kite, Novartis, NuProbe, Pfizer, PharmaEssentia, Stemline.

Allison P Wheeler, MD, MSCI

Director of Research at Washington Center for Bleeding Disorders
Associate Professor, University of Washington School of Medicine
Division of Pediatric Hematology/Oncology & Division of Hematology and Oncology
Seattle, Washington

Allison Wheeler, MD, MSCI: consultant/advisor/speaker: Bayer, Bioverativ, CSL Behring, HEMA Biologics, Novo Nordisk, Octapharma, Pfizer, Sanofi, Takeda.

Amer Zeidan, MBBS, MHS

Associate Professor of Medicine (Hematology)
Chief, Division of Hematologic Malignancies
Yale Comprehensive Cancer Center and Smilow Cancer Hospital
New Haven, Connecticut

Amer Zeidan, MBBS, MPH: researcher: AbbVie, ADC Therapeutics, Amgen, Aprea, Astex, Boehringer Ingelheim, Cardiff Oncology, Celgene/Bristol-Myers Squibb, Incyte, Medimmune/AstraZeneca, Novartis, Otsuka, Pfizer, Takeda, Trovagene; consultant: Acceleron, Agios, Amgen, Aprea, Astellas, Astex, BeyondSpring, Boehringer Ingelheim, Cardiff Oncology, Cardinal Health, Celgene/Bristol-Myers Squibb, Daiichi Sankyo, Epizyme, Gilead Sciences, Incyte, Ionis, Janssen, Jazz, Kura, Novartis, Otsuka, Pfizer, Seattle Genetics, Syndax, Taiho, Takeda, Trovagene, Tyme.